Pratibha Panwar
Has grant
Research Associate
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Molecular epidemiology and resistance patterns of mycobacterial isolates from a cancer hospital
Open Date:
Close Date:
Articles (17)
Year:
2026
The accumulation of pathogenic mutations in premalignant colorectal neoplasms is critical for colorectal cancer development; however, the frequency and diversity of pathogenic driver mutations in early-stage colorectal polyps is incompletely known. We investigated this by whole-exome sequencing of low-grade dysplasia (LGD) colorectal polyps and paired germline DNA. Interestingly, in these early lesions, there was no association with mutational burden and the known risk factor of polyp size (range, 3–15 mm). However, a subset of LGD polyps harbored concurrent, oncogenic alterations in colorectal cancer–causing pathways of WNT/β-catenin, p53, or RTK-RAS. Further analysis suggested that the concurrent mutation signature was associated with increased polyp burden. Spatial transcriptomic analysis revealed that immune effectors, including NF-κB signaling, were a characteristic of LGD polyps with concurrent pathogenic mutations. Together, these observations suggest that some small-sized, early colorectal neoplasms have enhanced oncogenic potential and highlight that nonadvanced colorectal adenoma may not be universally considered a low-risk finding. Significance: Through whole-exome sequencing of early colorectal polyps characterized by LGD, we demonstrate that polyp size poorly correlates with mutational burden. Some small-sized (<10 mm polyps) early polyps harbored concurrent driver gene mutations commonly seen in adenocarcinoma. Sequencing of key driver genes in early polyps may identify risky lesions that cannot be detected by histology alone.
Year:
2025
Motivation Mutual nearest neighbors (MNN) is a widely used computational tool to perform batch correction for single-cell RNA-sequencing data. However, in applications such as spatial transcriptomics, it fails to take into account the 2D spatial information. Results Here, we present spatialMNN, an algorithm that integrates multiple spatial transcriptomic samples and identifies spatial domains. Our approach begins by building a k-nearest neighbors (kNN) graph based on the spatial coordinates, prunes noisy edges, and identifies niches to act as anchor points for each sample. Next, we construct a MNN graph across the samples to identify similar niches. Finally, the spatialMNN graph can be partitioned using existing algorithms, such as the Louvain algorithm to predict spatial domains across the tissue samples. We demonstrate the performance of spatialMNN using large datasets, including one with N = 31 10x Genomics Visium samples. We also evaluate the computing performance of spatialMNN to other popular spatial clustering methods. Availability and implementation Our software package is available on GitHub (https://github.com/Pixel-Dream/spatialMNN). The code is available on Zenodo (https://doi.org/10.5281/zenodo.15073963).
Year:
2025
Advances in spatially‐resolved transcriptomics (SRT) technologies have propelled the development of new computational analysis methods to unlock biological insights. The lowering cost of SRT data generation presents an unprecedented opportunity to create large‐scale spatial atlases and enable population‐level investigation, integrating SRT data across multiple tissues, individuals, species, or phenotypes. Here, unique challenges are described in the SRT data integration, where the analytic impact of varying spatial and biological resolutions is characterized and explored. A succinct review of spatially‐aware integration methods and computational strategies is provided. Exciting opportunities to advance computational algorithms amenable to atlas‐scale datasets along with standardized preprocessing methods, leading to improved sensitivity and reproducibility in the future are further highlighted.
Year:
2025
Year:
2025
The increased uptake of high-resolution spatially-resolved transcriptomics (SRT) technologies demands the development of unsupervised methods to extract cell types and their spatial distribution from biological tissues. However, unsupervised clustering is challenging due to the sparsity of the data and the differences in cell arrangement within tissues. Here, we introduce ClustSIGNAL, a spatial clustering method that adaptively uses neighbourhood information to overcome data sparsity and perform cell type clustering. ClustSIGNAL first defines initial clusters and sub-clusters of cells with similar gene expression patterns. For each cell, a fixed neighbourhood size is defined, and entropy is calculated based on the proportion of initial subclusters in the neighbourhood to capture its composition. Cell-specific weights, generated from entropy values, are used to embed spatial information into the gene expression through adaptive smoothing. The transformed gene expression is then used for clustering cell types. We compared our adaptive smoothing approach with other smoothing scenarios on four simulated datasets of varying spatial complexity. We also evaluated our clustering method on four publicly available high-resolution SRT datasets and compared its performance to that of three other spatial clustering methods. We showed that ClustSIGNAL performs multi-sample clustering with high accuracy and can identify subtle cell types and subtypes of biological relevance. It is also robust to changes in spatial structure of tissues, segmentation errors, and sparsity. Overall, ClustSIGNAL stabilises gene expression of cells in homogeneous neighbourhoods and preserves distinct gene expression of cells in heterogeneous regions, effectively balancing the use of neighbouring cells as prior knowledge for downstream analysis. The ClustSIGNAL R/Bioconductor package is available from bioconductor.org/packages/clustSIGNAL .
Year:
2025
Spatial transcriptomics technologies provide spatially-resolved measurements of gene expression through assays that can either target selected genes or capture transcriptome-wide expression profiles. The complexity and variability of these technologies and their associated data necessitate multi-step workflows integrating diverse computational methods and software packages. We provide a freely accessible, open-source, continuously updated and tested online book containing reproducible code examples, datasets, and discussion about data analysis workflows for spatial omics data using Bioconductor in R, including interoperability with Python.
Year:
2025
The most frequently altered oncogenic pathways reported in TCGA adenocarcinoma data was mapped to bowel polyp specimens analyzed in this study (tubulovillous adenoma (TVA), tubular adenomas (TA), sessile serrated lesions (SSL) and hyperplastic (HP), and normal healthy colon data.
Year:
2025
Oncogenic mutations defining a concurrent mutation signature in bowel polyps. A, Venn diagram to show the selection criterion of polyps with concurrent mutations in two of three molecular pathways. B, Oncogenic mutations in low-grade polyps with concurrent mutations. C, Oncogenic mutations in low-grade polyps without concurrent mutations. D, Box plot of MB between polyp groups, colorectal cancer CRC, and normal mucosa (top and bottom quartiles and mean are shown; the top whisker is the maximum value plus 1.5 × IQR, and the bottom whisker is the minimum value minus 1.5 × IQR). TMB, tumor MB; ns, not significant.
Year:
2025
Mutational burden in different bowel neoplasia. Mann-Whitney U test comparison shows no significance between large and small polyps in the groups of tubular adenomas (TA), tubulovillous adenoma (TVA) and sessile serrated lesions (SSL).
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Collaborators (26)
Peiying Cai
University of Zurich
Levi Waldron
Professor
New York University
Davide Risso
Associate Professor
University of Padova
Stephanie Hicks
Associate Professor
Johns Hopkins University Bloomberg School of Public Health
Chahaya Gauci
Conjoint Associate Lecturer
University of New South Wales
Mark Robinson
Full Professor (of Statistical Genomics)
University of Zurich
Keri Martinowich
-
Kasper Hansen
Professor
Johns Hopkins University
Simone Tiberi
University of Zurich
Hanyun Zhang
Garvan Institute of Medical Research
Mark Molloy
Professor
University of Sydney
Martin Hemberg
Brigham and Women's Hospital
Raphael Gottardo
University of Lausanne
Ellis Patrick
Associate Professor
University of Sydney
Lukas M. Weber
Assistant Professor
Boston University
Calliope A Dendrou
Associate Professor in Clinical Pathology and Inflammation
University of Oxford
Jacqueline Siu
University of Oxford
Wodan Ling
Assistant Professor
Weill Cornell Medicine
Alexander Engel
Professor
University of Sydney
Dario Righelli
Tenure Track Assistant Professor
University of Padova
Leonardo Collado-Torres
Assistant Professor
Johns Hopkins University
Alexander Swarbrick
Senior Principal Research Fellow & Director of the Cancer Ecosystems Program
Garvan Institute of Medical Research
Ken Chen
Professor
The University of Texas MD Anderson Cancer Center
Boyi Guo
Assistant Professor
University of Utah Health
Pieter Meysman
Associate professor
University of Antwerp
Shila Ghazanfar
Lecturer
University of Sydney
Make your next move.
Prepare your application
Review drafts before you send them.